Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-01

Clinical Trial Update: Prospective Study of Serum Marker LncRNA RP5-977B1 in Pulmonary Nodules

View source ↗

Summary

Prospective study investigating the serum biomarker lncRNA RP5-977B1 in patients with pulmonary nodules; no results or status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Tumor of Lung, Pulmonary Nodule | Status: UNKNOWN